Insider · CIK 0001209726

BUCHI J KEVIN

Reports to the SEC for 13 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001209726

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-17	AMRXAmneal Pharmaceuticals, Inc.G Gift	Director	GGift	−20.4K sh	—	—	75,077
2026-09-11	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20.4K sh	$14.45	+$295K	95,522
2026-09-11	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−20.4K sh	—	—	0
2026-08-11	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	−169K sh	$17.18	−$2.9M	93,499
2026-06-29	BNTCBenitec Biopharma Inc.G Gift	Director	GGift	−51.8K sh	—	—	52,097
2026-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.8K sh	—	—	75,077
2026-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−34.8K sh	—	—	0
2026-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+19.8K sh	—	—	19,824
2025-12-01	BNTCBenitec Biopharma Inc. · Options (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2025-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+34.8K sh	—	—	34,819
2025-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−40.3K sh	—	—	0
2025-05-05	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40.3K sh	—	—	40,258
2025-03-12	BNTCBenitec Biopharma Inc.G Gift	Director	GGift	−104K sh	—	—	284
2025-03-12	BNTCBenitec Biopharma Inc.G Gift	Director	GGift	+104K sh	—	—	103,626
2025-03-10	AMRXAmneal Pharmaceuticals, Inc.G Gift	Director	GGift	−262K sh	—	—	0
2025-02-27	BNTCBenitec Biopharma Inc. · Common Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−51.8K sh	—	—	0
2025-02-27	BNTCBenitec Biopharma Inc.M Exercise/Conversion	Director	MExercise/Conversion	+51.8K sh	$3.86	+$200K	103,910
2024-12-09	BNTCBenitec Biopharma Inc. · Options (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2024-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+76.5K sh	—	—	262,072
2024-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−76.5K sh	—	—	0
2024-05-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+40.3K sh	—	—	40,258
2023-12-06	BNTCBenitec Biopharma Inc. · Options (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-08-11	BNTCBenitec Biopharma Inc. · Common Warrants (right to buy)P Purchase	Director	PPurchase	+51.8K sh	—	—	51,813
2023-08-11	BNTCBenitec Biopharma Inc.P Purchase	Director	PPurchase	+51.8K sh	—	—	52,097
2023-06-09	Ampio Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+21.9K sh	$0.29	+$6,284.175	146,858
2023-06-08	Ampio Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+25K sh	$0.30	+$7,400	125,000
2023-05-16	Ampio Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+32.5K sh	$0.27	+$8,924.076	100,000
2023-05-15	Ampio Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+44K sh	$0.25	+$10.9K	67,466
2023-05-12	Ampio Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+23.4K sh	$0.24	+$5,513.088	23,440
2023-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−80.1K sh	—	—	0
2023-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+80.1K sh	—	—	185,619
2023-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+76.5K sh	—	—	76,453
2022-12-07	BNTCBenitec Biopharma Inc. · Options (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+80.1K sh	—	—	80,128
2022-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35.4K sh	—	—	0
2022-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35.4K sh	—	—	105,491
2021-12-30	Ampio Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,333 sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncU Disposition from Tender	Director	UDisposition from Tender	−4,666 sh	$38.25	−$178K	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2021-12-08	BNTCBenitec Biopharma Inc. · Options (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2021-10-21	Ampio Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+150K sh	—	—	150,000
2021-06-03	Dicerna Pharmaceuticals IncRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,666 sh	—	—	0
2021-06-03	Dicerna Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+4,666 sh	—	—	4,666
2021-06-03	Dicerna Pharmaceuticals IncRestricted Stock UnitsA Award	Director	AAward	+3,333 sh	—	—	3,333
2021-06-03	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Sep 214
BUCHI J KEVIN0001628280-26-062915
SEC(opens sec.gov)
Sep 144
BUCHI J KEVIN0001628280-26-061836
SEC(opens sec.gov)
Aug 134
BUCHI J KEVIN0001628280-26-056752
SEC(opens sec.gov)
Jun 304
BUCHI J KEVIN0001193125-26-290586
SEC(opens sec.gov)
May 84
BUCHI J KEVIN0001628280-26-032929
SEC(opens sec.gov)
Dec 34
BUCHI J KEVIN0001012975-25-000847
SEC(opens sec.gov)
May 84
BUCHI J KEVIN0001628280-25-024004
SEC(opens sec.gov)
Mar 134
BUCHI J KEVIN0001062993-25-005393
SEC(opens sec.gov)
Mar 124
BUCHI J KEVIN0001628280-25-012344
SEC(opens sec.gov)
Mar 34
BUCHI J KEVIN0001062993-25-004077
SEC(opens sec.gov)
Dec 114
BUCHI J KEVIN0001062993-24-020468
SEC(opens sec.gov)
May 144
BUCHI J KEVIN0001628280-24-023247
SEC(opens sec.gov)

Companies

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807